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Supplementary Figure 1: CIC localization dynamics are consistent across different cell 
types.  
a. Expression of endogenous CIC (red) and the nuclear envelope protein NUP62 (green) in the 
HOG line at cytokinesis. DNA was detected using DAPI staining (blue). Zoomed image of early 
cytokinesis (right) shows a punctate localization pattern for endogenous CIC throughout the 
decondensing nucleus (arrowheads). Scale bars: 10 µm and 5µm (zoomed image). 
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b. Expression of F-CIC-S (FLAG, red) and a-tubulin (green) in CICKO HEK cells stably 
expressing F-CIC-S (HEKF-CIC-S) during different stages of the cell cycle. Foci of CIC protein 
can be observed adjacent to decondensing chromosomes at early cytokinesis (arrow, bottom 
panel). 
c. Left: representative IF images of unsynchronized HEK (CICWT) and A9 (CICKO) cells at 
metaphase and telophase/cytokinesis. Microtubules (a-tubulin, green), DNA (DAPI, blue) and 
the cell membrane (b-catenin, red) were detected. DAPI staining alone is shown on the left of 
each image. CICKO cells (right) show defects in metaphase alignment and lagging chromosomes 
at telophase and cytokinesis (arrowheads). Scale bar: 10µm. Right: bar graphs show proportions 
of cells with defects at metaphase (top) and cytokinesis (bottom). Bars represent the mean of 
three independent experiments and error bars indicate s.e.m. *p < 0.05, **p < 0.01 (two-sided 
Student’s t-test). 
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Supplementary Figure 2. Loss of CIC is associated with chromosomal instability and 
aneuploidy. 
a. Representative interphase FISH images of CICWT (NHA) and CICKO (A2 and H9) cells. Red 
dots indicate marker (1p or 19q) and green dots indicate reference (1q, 19p; Methods).  
b-c. Proportion of cells with indicated p/q ploidy ratios for chromosome 1 (b) and q/p ploidy 
ratios for chromosome 19 (c). Top: ratios obtained using interphase FISH analysis (100 cells per 
cell line). Bottom: ratios obtained using DLP+ (range 266-287 cells per cell line). 
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Supplementary Figure 3. Transcript and protein expression of CIC and cell cycle 
regulators.  
a. Top: representative western blots showing expression of cell cycle proteins in synchronized 
CICWT (NHA) and CICKO (A2 and H9) cells collected over the course of cell cycle phases at 
indicated time points post-RO-3306 release (shown below phase labels). Tubulin was used as a 
loading control. Bottom: western blot quantifications for CICWT (NHA) and CICKO (A2 and H9 
combined) cells at indicated time point post-release. Data were obtained from at least three 
biological replicates. *p < 0.05 (two-sided student t-test comparing WT vs KO at each time 
point). 
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b. Representative western blot showing expression of select cyclins in unsynchronized CICWT 
(NHA) and CICKO (A2 and H9) cells. Relative fold-changes (RFC, using NHA as a reference) of 
densitometry quantifications of select cyclins, calculated as a ratio relative to the respective 
tubulin band, are shown below the western blots. Data were obtained from three independent 
biological replicates and the standard deviation (+/-) is also indicated. *p < 0.05 (two-sided 
Student’s t-test relative to NHA). 
c. Representative image showing CICWT (NHA) and CICKO (A2 and H9) cells isolated by mitotic 
shake-off (Methods) and stained with DAPI. Percentages indicate the fraction of cells in pro-
mitosis (mean from three biological replicates +/- standard deviation; n = at least 142 cells for 
each replicate). Scale bar: 10 µm 
d. mRNA expression of select mitotic kinases in unsynchronized cells (UN), synchronized cells 
at G2/M, and synchronized PM cells isolated by mitotic shake-off, as measured by RT-qPCR. 
Error bars indicate s.e.m. *p < 0.05 (one-way ANOVA with Holm-Sidak’s multiple comparison 
for each time point). 
e. Gene expression in unsynchronized CICKO (A2) cells expressing F-CIC-S or F-CIC-L cells, as 
measured by RT-qPCR. Bars represent the mean from three independent experiments and error 
bars indicate s.e.m.  
f. Enrichment of CIC binding to select sites relative to the NCR, as measured by ChIP-qPCR 
against CIC in unsychronized (UN) and G2/M CICWT (NHA) and CICKO (A2) cells. Bars 
represent the mean over three independent replicates and error bars represent s.e.m. 
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Supplementary Figure 4. Locations of forward and reverse primers used to assess CIC 
binding at PLK3 and HMGA1 by ChIP-qPCR. 
a-b. PLK3 (a) and HMGA1 (b) loci as shown on the UCSC genome browser. The regions tested 
for enrichment are indicated by black bars, and forward and reverse primer sequences are shown. 
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Supplementary Figure 5. IP-MS assays identify candidate CIC interactors. 
a. Schematic showing the workflow for IP-MS assays used to identify candidate CIC interactors 
(see Methods section). 
b. Western blots showing reciprocal IPs confirming the interaction between F-CIC-S (detected 
using a FLAG antibody) and SMARCA2 (top) and ARID1A (bottom) in HEKD10F-CIC-S cells.  
c. An UpSet plot showing common interactors identified from IP-MS experiments against CIC, 
SMARCA2, and ARID1A. 
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Supplementary Figure 6. CIC co-localizes with SMARCC1 and ARID2. 
a-b. IF images showing localization of F-CIC-S (FLAG, red) and SMARCC1 (a) or ARID2 (b, 
both green) at indicated phases of the cell cycle. DNA was stained with DAPI (blue). 
Arrowheads indicate co-localization of CIC and the relevant interactor at early cytokinesis 
(yellow foci). Scale bars: 10µm or as indicated for zoomed images (b). 
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Materials and Methods 
Cell culture 
The HEK293A cell line was obtained from Dr Gregg Morin (Canada’s Michael Smith 
Genome Sciences Centre, Vancouver, BC, Canada) and authenticated by Genetica DNA 
Laboratories (Cincinnati, OH, USA). The HOG cell line was obtained from Dr G. Dawson (The 
University of Chicago, Illinois, USA), and the IDH1-stable NHA cell line was obtained from 
Applied Biological Materials (ABM) Inc (T3022; Richmond, BC, Canada). The HEK293A, 
HOG and NHA cell lines were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 10% (v/v) heat-inactivated (HI) FBS (Invitrogen). Stable cell lines expressing 
F-CIC-S or F-CIC-F derived from HEK293A (D10) or NHA (A2) were cultured in DMEM+10% 
HI FBS with Zeocin (Invitrogen) selection. Cell culture was performed in a humidified, 37°C, 
5% CO2 incubator.  
 
CRISPR-Cas9 and knockout cell line generation and CIC expression constructs 
CRISPR-Cas9 sgRNA sequences were designed to target exon 2 of the CIC gene and 
CICKO lines were established from NHA (A2, H9, B6, and H10) and HEK293A (A9 and D10) 
cells as described previously27. CIC knockout status was verified by western blot and Sanger 
sequencing. N-terminal FLAG-CIC-short form (FLAG-CIC-S) and long form (FLAG-CIC-L) 
plasmids were prepared as described previously38. 
 
Cell cycle synchronization and mitotic shake off 
For immunofluorescence, we plated 1.3 x 105 cells/well in a 6-well plate with sterilized 
cover slips (CA48380-068, VWR). For western blot analyses, we plated 1.2 x 106 cells in 10 cm 
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tissue culture dishes. For RT-qPCR analyses, including mitotic shake off experiments, 1.2 x 106 
cells were plated in 3x T75 flasks (Falcon). After 48 h, freshly prepared 9µM RO-3306 
(SML0569, Sigma) in DMEM + 10% (v/v) HI FBS was added to initiate synchronization. After 
19 h, cells were washed with 1X Hank's Balanced Salt Solution (HBSS, Invitrogen) three 
times and were either released from treatment by addition of fresh media or terminated by 
pelleting or fixing with 4% paraformaldehyde (PFA). For mitotic-shake off experiments, mitotic 
cells were gently tapped and collected into a falcon tube 0.5 h post-release. Cell pellets were 
collected by centrifugation at 1000 rpm for 5 min.   
 
Immunofluorescence assays 
 For cell lines, fixed cells were permeabilized using 0.2% TritonX-100/PBS for 5 min, 
blocked with 2.5% goat serum (G6767, Sigma) in PBS for 1 h on a rocker, and stained with 
appropriate primary antibodies (Supplementary Table 6) in 0.25% goat serum in PBS overnight 
at 4°C. Alexa Fluor® 488 and/or 568 were used as secondary antibodies (Supplementary Table 
6), followed by mounting with DAPI (D3571, Invitrogen) and SlowFade™ Diamond Antifade 
Mountant (36967, Invitrogen). 
For mouse tissue, embryonic (E13.5) mouse brain section slides were quickly pre-washed 
in 1X TBST (0.1% Tween) followed by a 15 min permeabilization in TBST (0.25% Tween) and 
an additional 5 min wash in TBST (0.1% Tween) with gentle shaking. Slides were blocked with 
3% goat serum in 1X PBST (0.1% Tween), covered with parafilm, for 30 min in a humidified 
staining chamber. α-Phospho Histone H3 (Cell Signaling) and α-Rabbit Alexa Fluor® 568 
antibodies were applied in blocking solution overnight at 4°C and for 1 h at room temperature, 
respectively, with three 5 min TBST (0.1% Tween) washes performed in between. Slides were 
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then mounted for imaging and quantification. All steps were performed at room temperature 
unless indicated otherwise.  
 
Quantification of cell cycle phases and chromosomal defects 
To quantify cells at different cell cycle phases, 7-8 images were randomly captured per 
replicate at each time point with 20x magnification. Cells at interphase/prophase (pro-
metaphase), metaphase, and telophase/cytokinesis were counted and the proportion of cells at 
each phase relative to the total number of cells was calculated for each image, at each time point. 
Full cell counts can be found in Supplementary Table 7. 
For metaphase defects, 20-25 images per replicate were captured with 40x magnification. 
Normal, minor (a few alignment defects), and moderate-severe defective (severe alignments and 
multipolar alignments) phenotypes were observed, and the ratio of cells with a defective 
phenotype (number of cells with defective phenotypes in metaphase/total number of cells in 
metaphase) was calculated for each image. Metaphase cell counts for the NHA lines (Figure 1d): 
n = 146 (NHA), n = 104 (H9), and n = 99 (A2). Similarly, for cytokinesis defects, 50 images per 
replicate were captured with 63x (oil) magnification and the ratio of cells with a defective 
phenotype (number of cells with defective phenotypes in cytokinesis/ total number of cells in 
cytokinesis) was calculated for each image. Cytokinesis cell counts for the NHA lines: n = 122 
(NHA), n = 89 (H9), and n = 94 (A2). Cell counts for Figure 6b: n =  81 (NHA scr), n = 82 (A2 
scr), n = 70 (NHA ARID1AKD), and n = 75 (A2 ARID1AKD). Metaphase cell counts for the HEK 
line (Supplementary Figure 1c): n = 59 (HEK), n = 56 (D10), and n = 61 (A9). All images were 
captured with a Zeiss Axio Observer with Apotome.2 fluorescence microscope. 
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Mouse chromosomal defect counts 
E13.5 mouse brain29 section slides were mounted on glass slides and stored at −80°C 
until analysis. Each slide contained four consecutive sections each from two mice, for a total of 
eight sections per slide. α-tubulin (abcam) and DAPI DNA stain were used to quantify 
chromosomal defects and α-phospho-Histone H3 (Cell Signaling) was used to visualize 
mitotically active cells. For each brain section, images from 10 regions with cells in anaphase 
and telophase were captured at 63x (oil) magnification using an Axioplan microscope. The ratio 
of cells with defective anaphase or telophase to the total number of cells at anaphase or 
telophase, respectively, was used for quantifications. 
 
Cell lysis preparations 
Cell pellets were re-suspended in 4x packed cell volume of RIPA lysis buffer freshly 
supplemented with 1% sodium orthovanadate (100mM), 1% PMSF (200mM), 2% (v/v) protease 
inhibitor (sc-24948, Santa Cruz), and PhosSTOP (04906837001, Roche, following the 
manufacturer’s recommendations). Cell pellets were sonicated briefly and mixed for 1 h at 4°C 
on a rotator. Cellular debris was removed using centrifugation at 13000 rpm for 10 min at 4°C. 
Total protein was quantified using the Pierce™ BCA Protein Assay Kit (Thermo Fisher).   
 
Western blots 
Samples were subjected to gel electrophoresis on NuPage® 3-8% Tris Acetate or 10% 
Bis-Tris pre-cast mini-gels with 1x NuPage® MOPS buffer (Invitrogen). Separated proteins were 
transferred onto a methanol-activated PVDF membrane (162-0177, Bio-Rad) in 1x NuPage® 
Transfer buffer (Invitrogen) + 20% (v/v) methanol. Membranes were blocked with either 2% or 
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5% (w/v) skim milk in PBST or ReliaBLOT BLOCK (WB 120, Bethyl) in TBST for 1 h at room 
temperature prior to incubation with primary antibodies (Supplementary Table 6) at 4°C 
overnight. For protein detection, membranes were incubated with HRP-IgG goat α-mouse or α -
rabbit (1:5000, Santa Cruz), or ReliaBLOT α -Rabbit HRP (1:5000, Bethyl) for 1 h at room 
temperature followed by three PBST washes before application of ECL substrate (Bio-Rad) or 
SuperSignal West Femto substrate (Thermo Scientific). Images were captured using a 
ChemiDoc™ MP Imager and processed with Protein Image Lab 5.1 (Bio-Rad).  
 
Single-cell whole-genome sequencing (DLP+) 
DLP+ was performed as described33. Specifically, cells were harvested using 0.05% 
Trypsin-EDTA and passed through a 35µm filter (Falcon) to generate a single-cell suspension. 
Cells were then stained with CellTrace CFSE and LIVE/DEAD Fixable Red Dead stains 
(Thermo Fisher), washed with PBS (Gibco), and brought to a standard concentration of 220,000 
cells/mL. For each cell line, 300 single cells were spotted into individual wells of Wafergen Seq-
Ready TE FLEX chips (Takara) using a sciFLEXARRAYER S3 (Scienion) with the CellenONE 
software add-on. Ten no-cell negative control wells were also spotted from each cell suspension, 
and 10 additional wells were designated as no-template negative controls. After spotting, chips 
were imaged on a Nikon Ti-E Eclipse fluorescent microscope, and wells containing a single live 
cell were identified using in-house software. Cells were lysed in DirectPCR Lysis Reagent - Cell 
(Viagen) supplemented with QIAGEN Protease (Qiagen), and then the protease was heat-
inactivated. Twelve ng of HL60 genomic DNA was added to 10 wells as a positive control for 
lysis. Sequencing libraries were constructed using the Nextera DNA Library Prep kit (Illumina), 
with sequential addition and incubation of the reactions with Nextera tagmentation mix, 
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QIAGEN protease to degrade the tagmentation enzyme, and Nextera PCR mix. Eight cycles of 
PCR were performed using dual-indexing Nextera primers preloaded into chip wells prior to the 
experiment. Well contents for each cell line were recovered and pooled for cleanup with 1.8 
volumes of PCRClean DX magnetic beads (Aline) and sequencing on the HiSeq X platform 
(Illumina). 
 
DLP+ analysis 
Raw paired-end FASTQ files were trimmed with Skewer58 to remove any adapter 
sequence prior to alignment to the hg19 human reference with BWA mem (version 0.7.13)59. 
Aligned reads were sorted and duplicates marked using Sambamba60 (version 0.6.5) to provide a 
single BAM file for each sequenced cell. Only cells identified as live were used for downstream 
analyses (n = 273 NHA cells, 283 A2 cells, 287 B6 cells, 266 H9 cells, and 282 H10 cells). 
BAM files were converted to individual BED files and copy number and ploidy analysis was 
performed using Ginkgo61 with the following parameters: variable bin size of 500 kb, 150 bp 
simulated reads aligned with BWA, independent segmentation, and using the “mask bad bins” 
option. Ginkgo was run independently for each cell line on all libraries from wells identified as 
containing a live cell. The remaining analyses, including statistical tests, were performed in R. 
For calculation of chromosomal arm ratios, centrosome regions were obtained from the UCSC 
Genome Browser (hg19 gaps; https://genome.ucsc.edu/) and the median copy number across 
bins from each chromosomal arm was calculated. For segment quantifications, the number and 
median length of segments (i.e. regions of continuous copy number) was calculated for each 
copy number state (neutral, gain, or loss) for each cell. Copy number states were defined 
according to each cell’s ploidy as determined by Ginkgo: neutral segments were those with the 
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same copy number as the ploidy of that cell, and gain and loss segments were those with higher 
or lower copy number, respectively. Wilcoxon tests were used to evaluate differences in the 
distribution of segment numbers or lengths for each copy number status, using the parental NHA 
line as a reference. Adjusted p-values were obtained by applying a Bonferroni correction to p-
values obtained within each copy number status. 
 
Fluorescence in-situ hybridization (FISH) analysis 
Freshly pelleted cell cultures were fixed and re-suspended in a 3:1 ratio of 
methanol:acetic acid solution. For each culture, 20 µL of suspension was dropped onto each of 2 
slides and allowed to air dry for at least 30 min. Slides were then dehydrated through an alcohol 
series (70%, 80%, and 100%) and allowed to air dry at room temperature. Five µL of either 
1p36/1q25 or 19q13/19p13 Vysis dual-colored FISH probe (Abbott Molecular Inc.) was added to 
the corresponding slide. A coverslip was applied to each slide and sealed with rubber cement. 
Slides and probes were co-denatured at 73°C for 5 min and allowed to hybridize for 18 h at 37°C 
in a ThermoBrite System (Abbott Molecular Inc.). After hybridization, slides were soaked in 
0.4X SSC/0.3% NP-40 solution to remove the coverslip, washed in 0.4X SSC/0.3% NP-40 
solution at 73°C for 2 min and rinsed in 2X SSC/0.1% NP-40 solution for 1 min at room 
temperature. Slides were then allowed to dry upright and protected from light. Once dry, 10µL of 
DAPI counterstain (Abbott Molecular Inc.) was applied to each slide and overlaid with a 
coverslip.  
Slides were visualized and probe signals enumerated using a Metafer Slide Scanning Platform 
(MetaSystems) at 63X magnification. Spectrum orange-labeled target probe and spectrum green-
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labeled control probe signals were counted in a minimum of 100 nuclei for each slide to 
determine the 1p/1q or 19q/19p (orange/green) ratio. 
 
RNA extraction and RT-qPCR 
 Total RNA was extracted with the RNeasy Plus Mini Kit (74136, QIAGEN) following 
the manufacturer’s protocol and was quantified using an 8-sample spectrophotometer 
(NanoDrop). RT-qPCR was performed with 20 ng of input RNA using the Power SYBR® Green 
RNA-to-Ct1TM 1-Step Kit (4389986, Applied Biosystems) following the manufacturer’s 
recommendations. A QuantStudio 6 Flex Real-Time PCR system and the QuantStudio™ Real-
Time PCR Software v1.3 (Applied Biosystems) were used to obtain CT values. Relative mRNA 
expression levels were calculated using the 2ΔΔct method with GAPDH as an internal control. 
Student’s t-tests were used to calculate p-values using Microsoft Excel. RT-qPCR primer 
sequences are provided in Supplementary Table 8. 
 
Targeted ChIP-qPCR analysis 
Each replicate consisted of three ~70-80% confluent 15 cm plates. Cells were crosslinked 
using 1% formaldehyde (Sigma) in PBS for 10 min with gentle rocking, and then treated with 
0.125M glycine (Sigma) for 5 min. Crosslinked cells were collected by scraping, pooled, and 
then pelleted by centrifugation (1200 rpm for 5 min at 4oC). Cell pellets were resuspended in 
ChIP cytoplasmic lysis buffer (50mM HEPES-KOH pH7.5, 140mM NaCl, 1mM EDTA pH 8.0, 
10% glycerol, 0.5% NP-40, 0.25% Triton X-100, 1X Complete EDTA-free Protease Inhibitor 
cocktail [PIC, Roche], and 1X PhosSTOP [Roche]), homogenized using a 20-gauge needle (10 
passages) and lysed at 4oC for 1 h with end-to-end rotation. Lysed cells were pelleted at 5000 
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rpm for 5 min at 4oC, and washed twice with MNase lysis buffer (0.1% Triton X-100, 0.1% 
deoxycholate, 1X EDTA-free PIC, 1X PhosSTOP) to remove any cytoplasmic content. Nuclei 
were resuspended with 3x pellet volume MNase lysis buffer, to which 4x pellet volume of 
MNase Master Mix (1mM DTT, 2x MNase buffer [NEB]) was then added along with MNase 
(NEB, 1/100 final volume). MNase treatment was performed for 7 min at room temperature. To 
stop the reaction, 0.5M EGTA was added to a final concentration of 20 mM. MNase-digested 
nuclei were transferred to 1 mL milliTUBEs with AFA fiber (D-Mark Biosciences) with a 30-
gauge needle and then briefly sonicated to disrupt the nuclear membrane using a Covaris S2 
sonicator with the following settings: 20% duty, 4 intensity, 200 burst, 20 seconds, 4-8 oC). All 
subsequent steps, including chromatin quantification, pre-clearing, immunoprecipitation and 
qPCR were performed as described previously27. 
 
Cell fractionations of nuclear proteins and immunoprecipitation 
 HEK IPs were Cells were grown for 48 h and harvested at ~80% confluency. Fresh cell 
pellets were gently resuspended in 5x packed cell volume of cytoplasmic lysis buffer (10mM 
Tris-HCl pH7.2, 10mM NaCl, 2mM MgCl2, 1mM EDTA, 0.05% NP-40, with 1X complete 
protease inhibitor and 1X PhosSTOP from Roche). Lysates were incubated on ice for 10 min 
before centrifugation at 300g for 5 min to collect nuclear pellets. After 3 to 4 washes with wash 
buffer (10mM Tris-HCl pH7.2, 10mM NaCl, 2mM MgCl2, 1mM EDTA with 1X cOmplete 
protease inhibitor and 1X PhosSTOP from Roche), nuclear pellets were resuspended in 3x 
packed cell volume of nuclear lysis buffer (250mM NaCl, 20mM sodium phosphate pH7.0, 
30mM sodium pyrophosphate, 5mM EDTA, 10mM sodium fluoride, 10% glycerol, 1% NP-40, 
1mM DTT, with 1X complete protease inhibitor and 1X PhosSTOP from Roche) and then 
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homogenized using a 21-gauge needle. Cellular debris was removed by centrifugation at 13,000 
rpm for 30 min at 4°C and then nuclear protein was quantified using the Pierce™ BCA Protein 
Assay Kit (Thermo Fisher). Before proceeding with immunoprecipitation, nuclear lysates were 
treated with 0.1X Benzonase (EMD Millipore) for 30 min at 4°C. Antibody-bound magnetic 
beads were prepared by incubating anti-CIC antibody or normal rabbit-IgG (Supplementary 
Table 6) with Protein G Dynabeads® (Thermo Fisher) in PBST (0.1% v/v) at 4°C for 30 min, 
and then rinsed three times with wash buffer (1X PBS, 1mM EDTA, 0.5% NP40, with 1X 
complete protease inhibitor and 1X PhosSTOP from Roche). Nuclear lysates were incubated 
with the prepared anti-CIC or rabbit IgG (control) Protein-G beads at 4ºC overnight. Protein and 
protein complexes were released by boiling the magnetic beads in elution buffer (2X Nupage 
LDS buffer [Invitrogen], 200mM DTT) at 98oC for 10 min. 
 
Reciprocal immunoprecipitation 
 Whole-cell extracts were prepared by lysing fresh cell pellets with 2x packed cell volume 
of lysis buffer (25mM Tris-HCl pH7.4, 150mM NaCl, 1% NP-40, 5% glycerol, with 1X 
complete protease inhibitor and 1X PhosSTOP from Roche), followed by homogenization from 
10 passes through a 21-gauge needle. After 30 a min incubation on ice, lysis preparations were 
cleared of cellular debris by centrifugation at 13,000 rpm for 30 min at 4°C and resuspended in 
X. Whole-cell lysates were incubated with anti-ARID1A, anti-SMARCA2, anti-SMARCC2, 
anti-POLR2A, or mouse/rabbit-IgG antibodies (Supplementary Table 6) at 4ºC overnight. 
Proteins and complexes were captured by incubating antibody-lysate mixtures with Protein G 
Dynabeads® (ThermoFisher) for 1 h at 4°C. For elution, magnetic beads were boiled in elution 
buffer (2X Nupage LDS buffer (Invitrogen), 200mM DTT) at 98oC for 10 min.  
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LC-MS/MS 
The initial IP-MS analysis of nuclear fractions from HEK293A cells using an endogenous 
CIC antibody or anti-Myc for N-Myc-CIC-S (Supplementary Table 2) was performed as 
described previously38. Three replicates were performed against endogenous CIC, and one 
experiment was performed against N-terminal MYC-fused CIC stably expressed in HEK293 
cells. The IP-MS validation experiments performed in nuclear fractions of the NHA cell line 
were also performed in triplicate, as were the matched IgG controls. See below for 
methodological details.  
 
Protein elution, clean-up with SP3, and protease digestion 
Proteins in SDS loading buffer were purified using the SP3 method, as described 
previously62,63. A total of 200 µg of protein was prepared in a final volume of 100 µL in a 
standard 1.5 mL tube. Twenty µL (400 µg) of a 1:1 combination of two different types of 
carboxylate-functionalized beads, both with a hydrophilic surface (Sera-Mag Speed Beads, GE 
Life Sciences, CAT#45152105050350 and CAT#65152105050350), was added to the lysate, 
with the beads rinsed in water prior to addition to the lysate. To promote binding to the beads, 
100 µL of 90% ethanol was added to achieve a final concentration of 50% by volume (i.e. 45% 
ethanol final concentration). Tubes were mixed on a ThermoMixer unit (Eppendorf) at 1000rpm 
for 10 min at room temperature, then placed in a magnetic rack and incubated for 2 min. The 
supernatant was discarded, and the beads rinsed 3x with 180 µL of 90% ethanol by removing the 
tubes from the magnetic rack and gently re-suspending the beads using a brief sonication (30 s), 
followed by pipette mixing. For elution, the tubes were removed from the magnetic rack and 
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beads were re-suspended in 100 µL of 50 mM HEPES, pH 8 containing an appropriate amount 
of trypsin/rLysC mix (1:25 enzyme to protein concentration, Promega, CAT#V5071) and 
incubated for 14 h at 37°C in a ThermoMixer with mixing at 1000 rpm. After incubation, the 
tubes were sonicated briefly (30 s) in a bath sonicator, placed on a magnetic rack, and the 
supernatant was recovered for further processing. 
 
Synthetic peptide mix preparation 
The set of standard peptides was taken as a subset from the collection analyzed in the 
ProteomeTools initiative64. Peptides were selected for a panel of 51 genes, resulting in a set of 
254 total candidates that were synthesized in a ‘SpikeMix’ format (JPT Peptide Technologies). 
Upon delivery, dried peptides were reconstituted in 100 µL of DMSO, vortexed briefly (~15 s), 
and sonicated in a water bath for 5 min. Reconstituted peptides were measured in a dilution 
series to determine the concentration that represented the limit of detection for the majority of 
the pool. Reconstituted peptides were spiked into interactome samples at a concentration 10% 
above the determined limit of detection. In this way, the synthetic spikes would not negatively 
impact the resulting quantification of detected peptides due to a large difference in dynamic 
range in comparison to the IP samples. 
 
Tandem mass tag labeling of peptides 
TMT 6-plex labelling kits were obtained from Pierce. Each TMT label (5 mg per vial) 
was reconstituted in 500 µL of acetonitrile and refrozen. A maximum of 50 µg of combined 
peptide was present in any single channel. Labelling reactions were carried out through addition 
of 200 µg of TMT label in two volumetrically equal steps of 10 µL (100 µg per addition), 30 min 
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apart. IP samples were labelled using TMT126 – TMT131 labels. The synthetic peptide spikes 
were labelled using the TMT131C reagent (from the TMT 11-plex reagent set) to ensure no 
overlap with the samples. Reactions were quenched through addition of 10 µL of glycine (1M 
stock solution, Sigma). Labelled peptides were concentrated on a SpeedVac centrifuge (Thermo 
Scientific) to remove excess acetonitrile, acidified to 1% (v/v) trifluoroacetic acid (TFA), and 
purified with a C18 StageTips.  
 
Peptide clean-up procedures 
Peptides were desalted and concentrated using StageTip treatment as described 
previously65. For StageTip clean-up, 3-discs of C18 Empore material (Sigma, CAT#66883-U) 
packed in 200µL pipette tips were rinsed twice with 100µL of acetonitrile with 0.1% TFA. 
Cartridges were then rinsed twice with 100 µL of water with 0.1% TFA prior to sample loading. 
Loaded samples were rinsed twice with 0.1% formic acid (100 µL per rinse) and eluted with 100 
µL of 80% acetonitrile containing 0.1% formic acid. All TopTip- or StageTip-processed samples 
were concentrated in a SpeedVac centrifuge (Thermo Scientific) and subsequently reconstituted 
in 1% formic acid with 1% DMSO in water. 
 
MS analysis of peptide samples on the Orbitrap Fusion 
Analysis of TMT-labelled peptide pools was carried out on an Orbitrap Fusion Tribrid 
MS platform (Thermo Scientific). Samples were introduced using an Easy-nLC 1000 system 
(Thermo Scientific). Columns used for trapping and separations were packed in-house. Trapping 
columns were packed in 100 µm internal diameter capillaries to a length of 25 mm with C18 
beads (Reprosil-Pur, Dr. Maisch, 3 µm particle size). Trapping was carried out for a total volume 
 22 
of 10 µL at a pressure of 400 bar. After trapping, gradient elution of peptides was performed on a 
C18 (Reprosil-Pur, Dr. Maisch, 1.9µm particle size) column packed in-house to a length of 20 
cm in 100 µm internal diameter capillaries with a laser-pulled electrospray tip and heated to 
50°C using AgileSLEEVE column ovens (Analytical Sales & Service). Elution was performed 
with a gradient of mobile phase A (water and 0.1% formic acid) to 8% B (acetonitrile and 0.1% 
formic acid) over 5 min, to 30% B over 88 min, and to 40% B over 19 min, with final elution 
(80% B) using a further 8 min at a flow rate of 350 nL/min. 
Data acquisition on the Orbitrap Fusion was carried out using a data-dependent method 
with multi-notch synchronous precursor selection MS3 scanning for TMT tags. Survey scans 
covering the mass range of 350 – 1500 were acquired at a resolution of 120,000 (at m/z 200), 
with quadrupole isolation enabled, an S-Lens RF Level of 60%, a maximum fill time of 50 ms, 
and an automatic gain control (AGC) target value of 5e5. For MS2 scan triggering, monoisotopic 
precursor selection was enabled, charge state filtering was limited to 2 – 4, an intensity threshold 
of 5e3 was employed, and dynamic exclusion of previously selected masses was enabled for 60 s 
with a tolerance of 20 ppm. MS2 scans were acquired in the ion trap in Rapid mode after CID 
fragmentation with a maximum fill time of 150 ms, quadrupole isolation, an isolation window of 
1.6 m/z (0.2 m/z offset), collision energy of 30%, activation Q of 0.25, injection for all available 
parallelizable time turned OFF, and an AGC target value of 4e3. Fragment ions were selected for 
MS3 scans based on a precursor selection range of 400-1600 m/z, ion exclusion of 20 m/z low 
and 5 m/z high, and isobaric tag loss exclusion for TMT. The top 10 precursors were selected for 
MS3 scans that were acquired in the Orbitrap after HCD fragmentation (NCE 60%) with a 
maximum fill time of 150 ms, 50,000 resolution, 120-750 m/z scan range, ion injection for all 
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parallelizable time turned OFF, and an AGC target value of 1e5. The total allowable cycle time 
was set to 4 s. MS1 and MS3 scans were acquired in profile mode, and MS2 in centroid format. 
 
Mass spectrometry data analysis 
Data from the Orbitrap Fusion were processed using the Proteome Discoverer Software 
(v2.1.1.21). MS2 spectra were searched using Sequest HT against a combined UniProt human 
proteome database appended to a list of common contaminants (24,624 total sequences). Sequest 
HT parameters were specified as: trypsin enzyme, 2 missed cleavages allowed, minimum peptide 
length of 6, precursor mass tolerance of 20 ppm, and a fragment mass tolerance of 0.6. Oxidation 
of methionine, and TMT 6-plex at lysine and peptide N-termini were set as variable 
modifications. Carbamidomethylation of cysteine was set as a fixed modification. Peptide 
spectral match error rates were determined using the target-decoy strategy coupled to Percolator 
modeling of positive and false matches66,67. Data were filtered at the peptide spectral match-level 
to control for false discoveries using a q-value cut off of 0.01 as determined by Percolator. 
Contaminant and decoy proteins were removed from all data sets prior to downstream analysis. 
Perseus (v1.5.2.6) was used to perform two-sided t-tests to identify proteins that were 
significantly enriched in each IP experiment compared to their respective IgG controls (FDR < 
0.05). 
 
Proximity ligation assays (PLAs)  
Cells were plated on an 8-well CC2 chamber slide with cover (12-565-1, Fisher) in 
growth media. After 19 h, cells were fixed with 4% PFA. PLAs were performed using the 
Duolink® In Situ Red Starter Kit Mouse/Rabbit (DUO92101, Sigma), following the 
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manufacturer’s protocol. High-resolution images were obtained with an Eclipse Ti inverted 
confocal microscope equipped with A1 si laser (Nikon) and Rolera EM-C2TM (QImaging) 
camera. Images used for quantifications were obtained with an Axio Observer inverted fluoresce 
microscope (Zeiss), equipped with Apotom.2 and AxioCam MRm camera. Images were obtained 
at 40x or 63x (oil) magnification using the Zen software (2.3, blue edition; Zeiss). PLA dots 
were counted using Blob-Finder software (http://www.cb.uu.se/~amin/BlobFinder/). Nuclei 
counts (Figure 5a): n = 732 for ARID1A/CIC, 583 for ARID1A/vector, 564 for SMARCA2/CIC, 
533 for SMARCA2/vector, 563 for SMARCC1/CIC, 532 for SMARCC1/vector, 564 for 
ARID2/CIC, and 588 for ARID2/vector. Metaphase cell counts (Figure 5b): n = 25 for 
ARID1A/vector and n = 26 for ARID1A/CIC. Early cytokinesis cell counts: n = 40 for 
ARID1A/vector and n = 32 or ARID1A/CIC. 
 
Microscopy imaging 
 Microscope information is included in relevant sections. Raw images were further 
processed in Photoshop (Adobe).   
 
Crystal violet cell proliferation assays and siRNA transfections 
 Crystal violet assays were performed as previously described38. For siRNA experiments, 
cells were transected with 7nM of ARID1A siRNA (hs.Ri.ARID1A.13.2) or Scrambled Negative 
Control DsiRNA (51-01-19-08, IDT) using Opti-MEM™ and Lipofectamine™ RNAiMAX 
(Invitrogen), as previously described27.  
 
 25 
Statistical analysis 
 Statistical analysis was performed using Prism GraphPad unless otherwise indicated. 
Statistical significance was calculated using a two-sided Student’s t-test, Welch’s t-test, one-way 
ANOVA with Holm-Sidak multiple comparisons, or Wilcoxon test as described in the figure 
legends.  
 
Code availability 
 Code is available upon request. 
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